Daniel Drucker
Dr. Drucker received his M.D. from the University of Toronto in 1980, and is currently Professor of Medicine at the University of Toronto. He holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His laboratory is based in the Lunenfeld Tanenbaum Research Institute at Mt. Sinai Hospital and studies the molecular biology and physiology of the glucagon-like peptides. Dr. Drucker's scientific studies identified multiple novel mechanisms of gut hormone action, enabling development of new drug classes for diabetes, obesity and intestinal failure. His discoveries have been recognized by numerous learned societies including the Banting Award from the ADA, the Claude Bernard Award from the EASD, the Manpei Suzuki International Prize for Diabetes Research, the Rolf Luft Award from the Karolinska Institute, the Harrington-ASCI Prize for Innovation in Medicine, and election to Fellowship, the Royal Society, London.
Abstracts this author is presenting:
